A Pilot Study to Test Whether Systemic Interferon Gamma Increases Tumor Class I MHC Expression in Patients With Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Phase of Trial: Phase II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Interferon gamma-1b (Primary)
- Indications Liposarcoma; Synovial sarcoma
- Focus Biomarker; Pharmacodynamics
- 07 Jun 2017 Biomarkers information updated
- 12 Apr 2016 Planned primary completion date changed from 1 Apr 2016 to 1 Apr 2017.
- 16 Oct 2015 Planned primary completion date changed from 1 Oct 2015 to 1 Apr 2016 as reported by ClinicalTrials.gov.